Skip to main content

BlackBarn Capital Partners LP

13F filer · CIK 0002010204
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$1.19BU.S. long equity reported on 13F
Positions175 new · 2 closed
Net flow last quarter-$19.3MBuys minus sells
Top 10 positions weight27.6%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202617 positions
ROIVRoivant Sciences Ltd.$70.8M5.97%0.28%-12.5%Q4 2023
PRVAPrivia Health Group, Inc.$40.8M3.44%1.26%Not reportedQ4 2023
DHCDiversified Healthcare Trust$37.9M3.20%1.68%-15.3%Q4 2023
NEENextera Energy Inc$29.4M2.48%0.02%Not reportedQ2 2025
NIQNIQ Global Intelligence plc$27.2M2.29%0.98%+40.0%Q4 2025
UNHUnitedhealth Group Inc$27M2.28%0.01%Not reportedQ4 2023
NXPINXP Semiconductors N.V.$25.3M2.13%0.04%+50.0%Q1 2026
VKTXViking Therapeutics, Inc.$23.4M1.97%0.51%-3.5%Q2 2025
MHMcGraw Hill, Inc.$23.2M1.96%1.28%+17.3%Q3 2025
AMRXAmneal Pharmaceuticals, Inc.$22.5M1.90%0.41%-21.2%Q1 2024
VGVenture Global, Inc.$19.5M1.64%Not reportedNewQ2 2026
AZULAzul SA$15.1M1.28%0.18%NewQ2 2026
OXYOccidental Petroleum Corp$12.1M1.02%0.03%NewQ2 2026
ABUSArbutus Biopharma Corp$12M1.01%1.27%Not reportedQ1 2024
CRCCalifornia Resources Corp$9.25M0.78%0.20%NewQ2 2026
CCOICogent Communications Holdings, Inc.$3.47M0.29%0.49%-50.0%Q1 2025
SEATVivid Seats Inc.$3.26M0.28%4.55%Not reportedQ1 2026
Q1 2026Reported May 15, 202614 positions
ROIVRoivant Sciences Ltd.$63.3M5.09%0.32%-25.9%Q4 2023
VECOVeeco Instruments Inc$33.9M2.72%1.64%NewQ1 2026
PRVAPrivia Health Group, Inc.$32.6M2.62%1.26%+21.9%Q4 2023
DHCDiversified Healthcare Trust$32M2.57%1.99%-26.3%Q4 2023
NEENextera Energy Inc$31.1M2.50%0.02%Not reportedQ2 2025
MHMcGraw Hill, Inc.$28.6M2.30%1.09%+49.2%Q3 2025
NIQNIQ Global Intelligence plc$23.6M1.90%0.70%+15.3%Q4 2025
AMRXAmneal Pharmaceuticals, Inc.$20.5M1.65%0.52%+5.1%Q1 2024
VKTXViking Therapeutics, Inc.$20.2M1.63%0.54%+13.0%Q2 2025
NXPINXP Semiconductors N.V.$11.8M0.95%0.02%NewQ1 2026
ABUSArbutus Biopharma Corp$11.3M0.91%1.27%+35.1%Q1 2024
GBTGGlobal Business Travel Group, Inc.$11.2M0.90%0.38%NewQ1 2026
CCOICogent Communications Holdings, Inc.$9.42M0.76%1.00%-23.1%Q1 2025
SEATVivid Seats Inc.$2.96M0.24%4.64%NewQ1 2026
Q4 2025Reported Feb 17, 202611 positions
ROIVRoivant Sciences Ltd.$66.9M4.40%0.43%-29.9%Q4 2023
DHCDiversified Healthcare Trust$31.7M2.08%2.70%+6.2%Q4 2023
PRVAPrivia Health Group, Inc.$30.8M2.03%1.05%+19.2%Q4 2023
NIQNIQ Global Intelligence plc$29.7M1.95%0.61%NewQ4 2025
NEENextera Energy Inc$26.9M1.77%0.02%+24.1%Q2 2025
MHMcGraw Hill, Inc.$23.1M1.52%0.73%+64.6%Q3 2025
AMRXAmneal Pharmaceuticals, Inc.$19.8M1.30%0.50%-28.3%Q1 2024
VKTXViking Therapeutics, Inc.$19.3M1.27%0.48%+10.0%Q2 2025
CCOICogent Communications Holdings, Inc.$14M0.92%1.30%+73.3%Q1 2025
ABUSArbutus Biopharma Corp$8.9M0.59%0.96%-7.5%Q1 2024
ACLSAxcelis Technologies Inc$7.76M0.51%0.31%-51.7%Q4 2024
Q3 2025Reported Nov 14, 202515 positions
ROIVRoivant Sciences Ltd.$66.6M4.76%0.64%-4.9%Q4 2023
PRVAPrivia Health Group, Inc.$27.2M1.94%0.89%+45.4%Q4 2023
DHCDiversified Healthcare Trust$27.1M1.94%2.54%-1.6%Q4 2023
NXTNextpower Inc.$25.9M1.85%0.26%+12.9%Q1 2025
AMRXAmneal Pharmaceuticals, Inc.$21.9M1.57%0.70%-36.5%Q1 2024
NEENextera Energy Inc$20.4M1.46%0.01%+8.0%Q2 2025
TEVATeva Pharmaceutical Industries Ltd$20.2M1.45%0.09%-4.8%Q1 2024
ACLSAxcelis Technologies Inc$19.5M1.40%0.65%-44.4%Q4 2024
MOHMolina Healthcare, Inc.$18.2M1.30%0.19%+26.7%Q4 2023
CCOICogent Communications Holdings, Inc.$14.4M1.03%0.76%+56.3%Q1 2025
VKTXViking Therapeutics, Inc.$13.1M0.94%0.44%+42.9%Q2 2025
MHMcGraw Hill, Inc.$10.7M0.76%0.45%NewQ3 2025
ABUSArbutus Biopharma Corp$9.08M0.65%1.04%-23.2%Q1 2024
FBLAFB Bancorp, Inc.$7.51M0.54%3.15%Not reportedQ4 2024
BVFLBV Financial, Inc.$4.7M0.34%3.06%-39.3%Q4 2023
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.